Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ID-FISH Technology
Milpitas, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
ID-FISH Technology has received FDA clearance for its Lyme immunoblot diagnostic kits (iDart Lyme IgM and IgG ImmunoBlot Kits), showing high sensitivity and specificity versus standard methods. Its malaria FISH assays received FDA approval in 2017. Extensive clinical studies with leading reference labs (IGeneX) and the Bay Area Lyme Foundation confirm robust diagnostic accuracy for tick-borne diseases[6][2][3].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Diagnostic kitImmunoBlotFluorescence in situ hybridization
- Industry
- Molecular Diagnostics
02
Partnerships
IGeneX Laboratory
Beyond the preview
Go deeper on ID-FISH Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ID-FISH Technology.